Intriguingly, the expression of IL5 and IL9 was increased in ILC2s from PBMCs from NSCLC patients, but not in ILC2s from tumor tissues, compared with HD-derived PBMCs (Supplementary Figure 2B). Here, IL9 is linked to neoplasm.